Global Biosimilars Market by Manufacturers, Regions, Type and Application, Forecast to 2025

Published: Oct, 2019 | Pages: 107 | Publisher: XYZResearch
Industry: Medical Devices | Report Format: Electronic (PDF)

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Biosimilars in these regions, from 2012 to 2023 (forecast), covering
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    South America (Brazil, Argentina, Columbia)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Biosimilars market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Pfizer
    Sandoz International GmbH
    Teva Pharmaceuticals Industries
    Amgen Inc
    Biocon
    Dr. Reddy's Laboratories
    F. Hoffmann-La Roche
    Celltrion
    Samsung Bioepis
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
    Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
    Peptides (Glucagon, Calcitonin)
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Biosimilars for each application, including
    Oncology
    Blood Disorders

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

Global Biosimilars Market by Manufacturers, Regions, Type and Application, Forecast to 2025
1 Report Overview
    1.1 Definition and Specification
    1.2 Report Overview
        1.2.1 Manufacturers Overview
        1.2.2 Regions Overview
        1.2.3 Type Overview
        1.2.4 Application Overview
    1.3 Industrial Chain
        1.3.1 Biosimilars Overall Industrial Chain
        1.3.2 Upstream
        1.3.3 Downstream
    1.4 Industry Situation
        1.4.1 Industrial Policy
        1.4.2 Product Preference
        1.4.3 Economic/Political Environment
    1.5 SWOT Analysis
2 Product Type Market
    2.1 World Product Type Market Performance and Trend
        2.1.1 World Market Performance
        2.1.2 Different Type of Market Performance
    2.2 North America Product Type Market Performance and Trend
        2.2.1 North America Market Performance
        2.2.2 Different Type of Market Performance
    2.3 Europe Product Type Market Performance and Trend
        2.3.1 Europe Market Performance
        2.3.2 Different Type of Market Performance
    2.4 Asia-Pacific Product Type Market Performance and Trend
        2.4.1 Asia-Pacific Market Performance
        2.4.2 Different Type of Market Performance
    2.5 South America Product Type Market Performance and Trend
        2.5.1 South America Market Performance
        2.5.2 Different Type of Market Performance
    2.6 Middle East and Africa  Product Type Market Performance and Trend
        2.6.1 Middle East and Africa  Market Performance
        2.6.2 Different Type of Market Performance
3 Product Application Market
    3.1 World Product Application Market Performance and Trend
        3.1.1 World Market Performance
        3.1.2 Different Applications of Market Trend
    3.2 North America Product Application Market Performance and Trend
        3.2.1 North America Market Performance
        3.2.2 Different Applications of Market Trend
    3.3 Europe Product Application Market Performance and Trend
        3.3.1 Europe Market Performance
        3.3.2 Different Applications of Market Trend
    3.4 Asia-Pacific Product Application Market Performance and Trend
        3.4.1 Asia-Pacific Market Performance
        3.4.2 Different Applications of Market Trend
    3.5 South America Product Application Market Performance and Trend
        3.5.1 South America Market Performance
        3.5.2 Different Applications of Market Trend
    3.6 Middle East and Africa  Product Application Market Performance and Trend
        3.6.1 Middle East and Africa  Market Performance
        3.6.2 Different Applications of Market Trend
4 Manufacturers Profiles/Analysis
    4.1 Pfizer
        4.1.1 Pfizer Profiles
        4.1.2 Pfizer Product Information
        4.1.3 Pfizer Biosimilars Business Performance
        4.1.4 Pfizer Biosimilars Business Development and Market Status
    4.2 Sandoz International GmbH
        4.2.1 Sandoz International GmbH Profiles
        4.2.2 Sandoz International GmbH Product Information
        4.2.3 Sandoz International GmbH Biosimilars Business Performance
        4.2.4 Sandoz International GmbH Biosimilars Business Development and Market Status
    4.3 Teva Pharmaceuticals Industries
        4.3.1 Teva Pharmaceuticals Industries Profiles
        4.3.2 Teva Pharmaceuticals Industries Product Information
        4.3.3 Teva Pharmaceuticals Industries Biosimilars Business Performance
        4.3.4 Teva Pharmaceuticals Industries Biosimilars Business Development and Market Status
    4.4 Amgen Inc
        4.4.1 Amgen Inc Profiles
        4.4.2 Amgen Inc Product Information
        4.4.3 Amgen Inc Biosimilars Business Performance
        4.4.4 Amgen Inc Biosimilars Business Development and Market Status
    4.5 Biocon
        4.5.1 Biocon Profiles
        4.5.2 Biocon Product Information
        4.5.3 Biocon Biosimilars Business Performance
        4.5.4 Biocon Biosimilars Business Development and Market Status
    4.6 Dr. Reddy's Laboratories
        4.6.1 Dr. Reddy's Laboratories Profiles
        4.6.2 Dr. Reddy's Laboratories Product Information
        4.6.3 Dr. Reddy's Laboratories Biosimilars Business Performance
        4.6.4 Dr. Reddy's Laboratories Biosimilars Business Development and Market Status
    4.7 F. Hoffmann-La Roche
        4.7.1 F. Hoffmann-La Roche Profiles
        4.7.2 F. Hoffmann-La Roche Product Information
        4.7.3 F. Hoffmann-La Roche Biosimilars Business Performance
        4.7.4 F. Hoffmann-La Roche Biosimilars Business Development and Market Status
    4.8 Celltrion
        4.8.1 Celltrion Profiles
        4.8.2 Celltrion Product Information
        4.8.3 Celltrion Biosimilars Business Performance
        4.8.4 Celltrion Biosimilars Business Development and Market Status
    4.9 Samsung Bioepis
        4.9.1 Samsung Bioepis Profiles
        4.9.2 Samsung Bioepis Product Information
        4.9.3 Samsung Bioepis Biosimilars Business Performance
        4.9.4 Samsung Bioepis Biosimilars Business Development and Market Status
5 Market Performance for Manufacturers
    5.1 Global Biosimilars Sales (K Units) and Market Share by Manufacturers 2014-2019
    5.2 Global Biosimilars Revenue (M USD) and Market Share by Manufacturers 2014-2019
    5.3 Global Biosimilars Price (USD/Unit) of Manufacturers 2014-2019
    5.4 Global Biosimilars Gross Margin of Manufacturers 2014-2019
    5.5 Market Concentration
6 Regions Market Performance for Manufacturers
    6.1 North America Market Performance for Manufacturers
        6.1.1 North America Biosimilars Sales (K Units) and Share of Manufacturers 2014-2019
        6.1.2 North America Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2019
        6.1.3 North America Biosimilars Price (USD/Unit) of Manufacturers 2014-2019
        6.1.4 North America Biosimilars Gross Margin of Manufacturers 2014-2019
        6.1.5 Market Concentration
    6.2 Europe Market Performance for Manufacturers
        6.2.1 Europe Biosimilars Sales (K Units) and Share of Manufacturers 2014-2019
        6.2.2 Europe Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2019
        6.2.3 Europe Biosimilars Price (USD/Unit) of Manufacturers 2014-2019
        6.2.4 Europe Biosimilars Gross Margin of Manufacturers 2014-2019
        6.2.5 Market Concentration
    6.3 Asia-Pacific Market Performance for Manufacturers
        6.3.1 Asia-Pacific Biosimilars Sales (K Units) and Share of Manufacturers 2014-2019
        6.3.2 Asia-Pacific Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2019
        6.3.3 Asia-Pacific Biosimilars Price (USD/Unit) of Manufacturers 2014-2019
        6.3.4 Asia-Pacific Biosimilars Gross Margin of Manufacturers 2014-2019
        6.3.5 Market Concentration
    6.4 South America Market Performance for Manufacturers
        6.4.1 South America Biosimilars Sales (K Units) and Share of Manufacturers 2014-2019
        6.4.2 South America Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2019
        6.4.3 South America Biosimilars Price (USD/Unit) of Manufacturers 2014-2019
        6.4.4 South America Biosimilars Gross Margin of Manufacturers 2014-2019
        6.4.5 Market Concentration
    6.5 Middle East and Africa  Market Performance for Manufacturers
        6.5.1 Middle East and Africa  Biosimilars Sales (K Units) and Share of Manufacturers 2014-2019
        6.5.2 Middle East and Africa  Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2019
        6.5.3 Middle East and Africa  Biosimilars Price (USD/Unit) of Manufacturers 2014-2019
        6.5.4 Middle East and Africa  Biosimilars Gross Margin of Manufacturers 2014-2019
        6.5.5 Market Concentration
7 World Market Performance Point
    7.1 World Biosimilars Sales (K Units) and Share by Regions and Countries 2014-2019
        7.1.1 World Biosimilars Sales (K Units) and Share by Regions 2014-2019
        7.1.2 Regional Sales (K Units) and Share by Countries 2014-2019
            7.1.2.1 Asia-Pacific Biosimilars Sales (K Units) and Share by Countries 2014-2019
            7.1.2.2 North America Biosimilars Sales (K Units) and Share by Countries 2014-2019
            7.1.2.3 Europe Biosimilars Sales (K Units) and Share by Countries 2014-2019
            7.1.2.4 South America Biosimilars Sales (K Units) and Share by Countries 2014-2019
            7.1.2.5 Middle East and Africa  Biosimilars Sales (K Units) and Share by Countries 2014-2019
    7.2 World Revenue (M USD) and Share by Regions and Countries 2014-2019
        7.2.1 World Revenue (M USD) and Share by Regions 2014-2019
        7.2.2 Regional Revenue (M USD) and Share by Countries 2014-2019
            7.2.2.1 Asia-Pacific Biosimilars Revenue (M USD) and Share by Countries 2014-2019
            7.2.2.2 North America Biosimilars Revenue (M USD) and Share by Countries 2014-2019
            7.2.2.3 Europe Biosimilars Revenue (M USD) and Share by Countries 2014-2019
            7.2.2.4 South America Biosimilars Revenue (M USD) and Share by Countries 2014-2019
            7.2.2.5 Middle East and Africa  Biosimilars Revenue (M USD) and Share by Countries 2014-2019
    7.3 World Price (USD/Unit) by Regions and Countries 2014-2019
        7.3.1 World Price (USD/Unit) by Regions 2014-2019
        7.3.2 Regional Price (USD/Unit) by Countries 2014-2019
            7.3.2.1 Asia-Pacific Biosimilars Price (USD/Unit) by Countries 2014-2019
            7.3.2.2 North America Biosimilars Price (USD/Unit) by Countries 2014-2019
            7.3.2.3 Europe Biosimilars Price (USD/Unit) by Countries 2014-2019
            7.3.2.4 South America Biosimilars Price (USD/Unit) by Countries 2014-2019
            7.3.2.5 Middle East and Africa  Biosimilars Price (USD/Unit) by Countries 2014-2019
    7.4 World Gross Margin by Regions and Countries 2014-2019
        7.4.1 World Gross Margin by Regions 2014-2019
        7.4.2 Regional Gross Margin and Share by Countries 2014-2019
            7.4.2.1 Asia-Pacific Biosimilars Gross Margin and Share by Countries 2014-2019
            7.4.2.2 North America Biosimilars Gross Margin and Share by Countries 2014-2019
            7.4.2.3 Europe Biosimilars Gross Margin and Share by Countries 2014-2019
            7.4.2.4 South America Biosimilars Gross Margin and Share by Countries 2014-2019
            7.4.2.5 Middle East and Africa  Biosimilars Gross Margin and Share by Countries 2014-2019
8 Development Trend for Regions and Countries (Sales Point)
   8.1 World Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
   8.2 Asia-Pacific Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.2.1 China Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.2.2 Japan Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.2.3 Korea Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.2.4 India Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.2.5 Southeast Asia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
   8.3 North America Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.3.1 United States Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.3.2 Canada Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.3.3 Mexico Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
   8.4 Europe Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.4.1 Germany Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.4.2 UK Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.4.3 France Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.4.4 Russia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.4.5 Italy Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
   8.5 South America Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.5.1 Brazil Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.5.2 Argentina Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.5.3 Columbia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
   8.6 Middle East and Africa  Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.6.1 Saudi Arabia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.6.2 UAE Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.6.3 Egypt Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.6.4 Nigeria Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.6.5 South Africa Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
9 Upstream Source, Technology and Cost
    9.1 Upstream Source
    9.2 Technology
    9.3 Cost
10 Channel Analysis
    10.1 Market Channel
    10.2 Distributors
11 Consumer Analysis
    11.1 Oncology Industry 
    11.2 Blood Disorders Industry 
12 Market Forecast 2020-2025
    12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2020-2025
        12.1.1 Global Biosimilars Sales (K Units), Revenue (M USD) and Market Share by Regions 2020-2025
        12.1.2 Global Biosimilars Sales (K Units) and Growth Rate 2020-2025
        12.1.3 Asia-Pacific Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.1.4 North America Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.1.5 Europe Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.1.6 South America Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.1.7 Middle East and Africa  Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
    12.2 World Biosimilars Sales (K Units) and Revenue (M USD) Forecast by Types 2020-2025
        12.2.1 Overall Market Performance
        12.2.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.2.3 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.2.4 Peptides (Glucagon, Calcitonin) Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
    12.3 World Biosimilars Market Forecast by Application 2020-2025
        12.3.1 Overall Market Performance
        12.3.2 Oncology Sales and and Growth Rate 2020-2025
        12.3.3 Blood Disorders Sales and and Growth Rate 2020-2025
    12.4 Price (USD/Unit) and Gross Profit Forecast
        12.4.1 Global Biosimilars Price (USD/Unit) Trend 2020-2025
        12.4.2 Global Biosimilars Gross Profit Trend 2020-2025
13 Conclusion

List of Tables and Figures
Figure Product Picture of Biosimilars
Table Product Specifications of Biosimilars
Table Manufacturers List in the Report
Table Manufacturers Market Share 2014-2019
Table Regions Overview in the Report
Table Product Type and Standard
Table Type Overview
Table Product Application and Standard
Table Application Overview in the Report
Figure Industry Chain Structure of Biosimilars
Table Industry News List of Biosimilars
Figure New Project SWOT Analysis of Biosimilars
Table World 2014-2019 Biosimilars Sales (K Units) by Type
Figure World Biosimilars Sales Market Share (%) by Type in 2014
Figure World Biosimilars Sales Market Share (%) by Type in 2019
Table World 2014-2019 BiosimilarsRevenue (M USD) by Type
Figure World BiosimilarsRevenue Market Share (%) by Type in 2014
Figure World BiosimilarsRevenue Market Share (%) by Type in 2019
Table World Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Sales (K Units) and Growth Rate
Figure World Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Sales (K Units) and Growth Rate
Table World Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Revenue (M USD) and Growth Rate
Figure World Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Revenue (M USD) and Growth Rate
Table World Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Figure World Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Table World Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Figure World Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Table World Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Figure World Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Table World Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Figure World Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Table North America 2014-2019 Biosimilars Sales (K Units) by Type
Figure North America Biosimilars Sales Market Share (%) by Type in 2014
Figure North America Biosimilars Sales Market Share (%) by Type in 2019
Table North America 2014-2019 BiosimilarsRevenue (M USD) by Type
Figure North America Biosimilars Revenue Market Share (%) by Type in 2014
Figure North America Biosimilars Revenue Market Share (%) by Type in 2019
Table North America Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Sales (K Units) and Growth Rate
Figure North America Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Sales (K Units) and Growth Rate
Table North America Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Revenue (M USD) and Growth Rate
Figure North America Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Revenue (M USD) and Growth Rate
Table North America Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Figure North America Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Table North America Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Figure North America Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Table North America Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Figure North America Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Table North America Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Figure North America Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Table Europe 2014-2019 Biosimilars Sales (K Units) by Type
Figure Europe Biosimilars Sales Market Share (%) by Type in 2014
Figure Europe Biosimilars Sales Market Share (%) by Type in 2019
Table Europe 2014-2019 BiosimilarsRevenue (M USD) by Type
Figure Europe BiosimilarsRevenue Market Share (%) by Type in 2014
Figure Europe BiosimilarsRevenue Market Share (%) by Type in 2019
Table Europe Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Sales (K Units) and Growth Rate
Figure Europe Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Sales (K Units) and Growth Rate
Table Europe Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Revenue (M USD) and Growth Rate
Figure Europe Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Revenue (M USD) and Growth Rate
Table Europe Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Figure Europe Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Table Europe Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Figure Europe Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Table Europe Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Figure Europe Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Table Europe Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Figure Europe Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Table Asia-Pacific 2014-2019 Biosimilars Sales (K Units) by Type
Figure Asia-Pacific Biosimilars Sales Market Share (%) by Type in 2014
Figure Asia-Pacific Biosimilars Sales Market Share (%) by Type in 2019
Table Asia-Pacific 2014-2019 BiosimilarsRevenue (M USD) by Type
Figure Asia-Pacific BiosimilarsRevenue Market Share (%) by Type in 2014
Figure Asia-Pacific BiosimilarsRevenue Market Share (%) by Type in 2019
Table Asia-Pacific Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Sales (K Units) and Growth Rate
Figure Asia-Pacific Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Sales (K Units) and Growth Rate
Table Asia-Pacific Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Revenue (M USD) and Growth Rate
Figure Asia-Pacific Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Revenue (M USD) and Growth Rate
Table Asia-Pacific Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Figure Asia-Pacific Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Table Asia-Pacific Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Figure Asia-Pacific Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Table Asia-Pacific Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Figure Asia-Pacific Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Table Asia-Pacific Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Figure Asia-Pacific Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Table South America 2014-2019 Biosimilars Sales (K Units) by Type
Figure South America Biosimilars Sales Market Share (%) by Type in 2014
Figure South America Biosimilars Sales Market Share (%) by Type in 2019
Table South America 2014-2019 BiosimilarsRevenue (M USD) by Type
Figure South America BiosimilarsRevenue Market Share (%) by Type in 2014
Figure South America BiosimilarsRevenue Market Share (%) by Type in 2019
Table South America Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Sales (K Units) and Growth Rate
Figure South America Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Sales (K Units) and Growth Rate
Table South America Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Revenue (M USD) and Growth Rate
Figure South America Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Revenue (M USD) and Growth Rate
Table South America Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Figure South America Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Table South America Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Figure South America Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Table South America Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Figure South America Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Table South America Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Figure South America Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Table Middle East and Africa  2014-2019 Biosimilars Sales (K Units) by Type
Figure Middle East and Africa  Biosimilars Sales Market Share (%) by Type in 2014
Figure Middle East and Africa  Biosimilars Sales Market Share (%) by Type in 2019
Table Middle East and Africa  2014-2019 BiosimilarsRevenue (M USD) by Type
Figure Middle East and Africa  BiosimilarsRevenue Market Share (%) by Type in 2014
Figure Middle East and Africa  BiosimilarsRevenue Market Share (%) by Type in 2019
Table Middle East and Africa  Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Sales (K Units) and Growth Rate
Figure Middle East and Africa  Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Sales (K Units) and Growth Rate
Table Middle East and Africa  Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Revenue (M USD) and Growth Rate
Figure Middle East and Africa  Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Revenue (M USD) and Growth Rate
Table Middle East and Africa  Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Figure Middle East and Africa  Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Table Middle East and Africa  Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Figure Middle East and Africa  Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Table Middle East and Africa  Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
 Figure Middle East and Africa  Peptides (Glucagon, Calcitonin) Sales (K Units) and Growth Rate
Table Middle East and Africa  Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Figure Middle East and Africa  Peptides (Glucagon, Calcitonin) Revenue (M USD) and Growth Rate
Table World 2014-2019 Biosimilars Sales (K Units) by Application
Figure World Biosimilars Sales Market Share (%) by Application in 2014
Figure World Biosimilars Sales Market Share (%) by Application in 2019
Table World  Oncology Sales (K Units) and Growth Rate
Figure World  Oncology Sales (K Units) and Growth Rate
Table World  Blood Disorders Sales (K Units) and Growth Rate
Figure World  Blood Disorders Sales (K Units) and Growth Rate
Table North America Biosimilars Sales (K Units) by Application 2014-2019
Figure North America Biosimilars Sales Market Share (%) by Application in 2014
Figure North America Biosimilars Sales Market Share (%) by Application in 2019
Table North America  Oncology Sales (K Units) and Growth Rate
Figure North America  Oncology Sales (K Units) and Growth Rate
Table North America  Blood Disorders Sales (K Units) and Growth Rate
Figure North America  Blood Disorders Sales (K Units) and Growth Rate
Table Europe 2014-2019 Biosimilars Sales (K Units) by Application
Figure Europe Biosimilars Sales Market Share (%) by Application in 2014
Figure Europe Biosimilars Sales Market Share (%) by Application in 2019
Table Europe  Oncology Sales (K Units) and Growth Rate
Figure Europe  Oncology Sales (K Units) and Growth Rate
Table Europe  Blood Disorders Sales (K Units) and Growth Rate
Figure Europe  Blood Disorders Sales (K Units) and Growth Rate
Table Asia-Pacific 2014-2019 Biosimilars Sales (K Units) by Application
Figure Asia-Pacific Biosimilars Sales Market Share (%) by Application in 2014
Figure Asia-Pacific Biosimilars Sales Market Share (%) by Application in 2019
Table Asia-Pacific  Oncology Sales (K Units) and Growth Rate
Figure Asia-Pacific  Oncology Sales (K Units) and Growth Rate
Table Asia-Pacific  Blood Disorders Sales (K Units) and Growth Rate
Figure Asia-Pacific  Blood Disorders Sales (K Units) and Growth Rate
Table South America 2014-2019 Biosimilars Sales (K Units) by Application
Figure South America Biosimilars Sales Market Share (%) by Application in 2014
Figure South America Biosimilars Sales Market Share (%) by Application in 2019
Table South America  Oncology Sales (K Units) and Growth Rate
Figure South America  Oncology Sales (K Units) and Growth Rate
Table South America  Blood Disorders Sales (K Units) and Growth Rate
Figure South America  Blood Disorders Sales (K Units) and Growth Rate
Table Middle East and Africa  2014-2019 Biosimilars Sales (K Units) by Application
Figure Middle East and Africa  Biosimilars Sales Market Share (%) by Application in 2014
Figure Middle East and Africa  Biosimilars Sales Market Share (%) by Application in 2019
Table Middle East and Africa   Oncology Sales (K Units) and Growth Rate
Figure Middle East and Africa   Oncology Sales (K Units) and Growth Rate
Table Middle East and Africa   Blood Disorders Sales (K Units) and Growth Rate
Figure Middle East and Africa   Blood Disorders Sales (K Units) and Growth Rate
Table Pfizer Profiles
Table Pfizer Product Information
Table Pfizer Biosimilars Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019
Table Pfizer Biosimilars Sales Change 2014-2019
Table Pfizer Biosimilars Market Status Change 2014-2019
Table Sandoz International GmbH Profiles
Table Sandoz International GmbH Product Information
Table Sandoz International GmbH Biosimilars Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019
Table Sandoz International GmbH Biosimilars Sales Change 2014-2019
Table Sandoz International GmbH Biosimilars Market Status Change 2014-2019
Table Teva Pharmaceuticals Industries Profiles
Table Teva Pharmaceuticals Industries Product Information
Table Teva Pharmaceuticals Industries Biosimilars Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019
Table Teva Pharmaceuticals Industries Biosimilars Sales Change 2014-2019
Table Teva Pharmaceuticals Industries Biosimilars Market Status Change 2014-2019
Table Amgen Inc Profiles
Table Amgen Inc Product Information
Table Amgen Inc Biosimilars Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019
Table Amgen Inc Biosimilars Sales Change 2014-2019
Table Amgen Inc Biosimilars Market Status Change 2014-2019
Table Biocon Profiles
Table Biocon Product Information
Table Biocon Biosimilars Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019
Table Biocon Biosimilars Sales Change 2014-2019
Table Biocon Biosimilars Market Status Change 2014-2019
Table Dr. Reddy's Laboratories Profiles
Table Dr. Reddy's Laboratories Product Information
Table Dr. Reddy's Laboratories Biosimilars Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019
Table Dr. Reddy's Laboratories Biosimilars Sales Change 2014-2019
Table Dr. Reddy's Laboratories Biosimilars Market Status Change 2014-2019
Table F. Hoffmann-La Roche Profiles
Table F. Hoffmann-La Roche Product Information
Table F. Hoffmann-La Roche Biosimilars Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019
Table F. Hoffmann-La Roche Biosimilars Sales Change 2014-2019
Table F. Hoffmann-La Roche Biosimilars Market Status Change 2014-2019
Table Celltrion Profiles
Table Celltrion Product Information
Table Celltrion Biosimilars Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019
Table Celltrion Biosimilars Sales Change 2014-2019
Table Celltrion Biosimilars Market Status Change 2014-2019
Table Samsung Bioepis Profiles
Table Samsung Bioepis Product Information
Table Samsung Bioepis Biosimilars Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019
Table Samsung Bioepis Biosimilars Sales Change 2014-2019
Table Samsung Bioepis Biosimilars Market Status Change 2014-2019
Table World Biosimilars Sales (K Units) of Manufacturers 2014-2019
Table World Biosimilars Sales Share of Manufacturers 2014-2019
Figure World Biosimilars Sales Share in 2014
Figure World Biosimilars Sales Share in 2019
Table World Revenue (M USD) of Manufacturers 2014-2019
Table World Revenue Share of Manufacturers 2014-2019
Figure World Revenue Share in 2014
Figure World Revenue Share in 2019
Table World Price (USD/Unit) of Manufacturers 2014-2019
Figure World Price (USD/Unit) of Manufacturers in 2014
Figure World Price (USD/Unit) of Manufacturers in 2019
Table World Gross Margin of Manufacturers 2014-2019
Figure World Gross Margin of Manufacturers in 2014
Figure World Gross Margin in 2019
Figure World Market Concentration 2014-2019
Table Top 3 Sales Share 2014-2019
Table Top 5 Sales Share 2014-2019
Table Top 8 Sales Share 2014-2019
Table Asia-Pacific Biosimilars Sales (K Units) of Manufacturers 2014-2019
Table Asia-Pacific Biosimilars Sales Share of Manufacturers 2014-2019
Figure Asia-Pacific Biosimilars Sales Share in 2014
Figure Asia-Pacific Biosimilars Sales Share in 2019
Table Asia-Pacific Biosimilars Revenue (M USD) of Manufacturers 2014-2019
Table Asia-Pacific Biosimilars Revenue Share of Manufacturers 2014-2019
Figure Asia-Pacific Biosimilars Revenue Share in 2014
Figure Asia-Pacific Biosimilars Revenue Share in 2019
Table Asia-Pacific Biosimilars Price (USD/Unit) of Manufacturers 2014-2019
Figure Asia-Pacific Biosimilars Price (USD/Unit) of Manufacturers in 2014
Figure Asia-Pacific Biosimilars Price (USD/Unit) of Manufacturers in 2019
Table Asia-Pacific Biosimilars Gross Margin of Manufacturers 2014-2019
Figure Asia-Pacific Biosimilars Gross Margin of Manufacturers in 2014
Figure Asia-Pacific Biosimilars Gross Margin in 2019
Figure Asia-Pacific Market Concentration 2014-2019
Table Top 3 Sales Share 2014-2019
Table Top 5 Sales Share 2014-2019
Table Top 8 Sales Share 2014-2019
Table North America Biosimilars Sales (K Units) of Manufacturers 2014-2019
Table North America Biosimilars Sales Share of Manufacturers 2014-2019
Figure North America Biosimilars Sales Share in 2014
Figure North America Biosimilars Sales Share in 2019
Table North America Biosimilars Revenue (M USD) of Manufacturers 2014-2019
Table North America Biosimilars Revenue Share of Manufacturers 2014-2019
Figure North America Biosimilars Revenue Share in 2014
Figure North America Biosimilars Revenue Share in 2019
Table North America Biosimilars Price (USD/Unit) of Manufacturers 2014-2019
Figure North America Biosimilars Price (USD/Unit) of Manufacturers in 2014
Figure North America Biosimilars Price (USD/Unit) of Manufacturers in 2019
Table North America Biosimilars Gross Margin of Manufacturers 2014-2019
Figure North America Biosimilars Gross Margin of Manufacturers in 2014
Figure North America Biosimilars Gross Margin in 2019
Figure North America Market Concentration 2014-2019
Table Top 3 Sales Share 2014-2019
Table Top 5 Sales Share 2014-2019
Table Top 8 Sales Share 2014-2019
Table Europe Biosimilars Sales (K Units) of Manufacturers 2014-2019
Table Europe Biosimilars Sales Share of Manufacturers 2014-2019
Figure Europe Biosimilars Sales Share in 2014
Figure Europe Biosimilars Sales Share in 2019
Table Europe Biosimilars Revenue (M USD) of Manufacturers 2014-2019
Table Europe Biosimilars Revenue Share of Manufacturers 2014-2019
Figure Europe Biosimilars Revenue Share in 2014
Figure Europe Biosimilars Revenue Share in 2019
Table Europe Biosimilars Price (USD/Unit) of Manufacturers 2014-2019
Figure Europe Biosimilars Price (USD/Unit) of Manufacturers in 2014
Figure Europe Biosimilars Price (USD/Unit) of Manufacturers in 2019
Table Europe Biosimilars Gross Margin of Manufacturers 2014-2019
Figure Europe Biosimilars Gross Margin of Manufacturers in 2014
Figure Europe Biosimilars Gross Margin in 2019
Figure Europe Market Concentration 2014-2019
Table Top 3 Sales Share 2014-2019
Table Top 5 Sales Share 2014-2019
Table Top 8 Sales Share 2014-2019
Table South America Biosimilars Sales (K Units) of Manufacturers 2014-2019